A detailed history of First Dallas Securities Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First Dallas Securities Inc. holds 4,103 shares of LLY stock, worth $3.73 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
4,103
Previous 4,203 2.38%
Holding current value
$3.73 Million
Previous $3.27 Million 13.58%
% of portfolio
1.64%
Previous 1.5%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $72,487 - $90,904
-100 Reduced 2.38%
4,103 $3.71 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 0.47%
4,203 $3.27 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $2.22 Million - $2.61 Million
4,223 New
4,223 $2.46 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $621 - $729
2 Added 0.04%
4,625 $1.59 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $160,775 - $187,335
500 Added 12.13%
4,623 $1.69 Million
Q3 2022

Oct 21, 2022

BUY
$296.48 - $337.87 $170,772 - $194,613
576 Added 16.24%
4,123 $1.33 Million
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $299,356 - $351,487
-1,074 Reduced 23.24%
3,547 $1.15 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $4,928 - $6,124
21 Added 0.46%
4,621 $1.32 Million
Q3 2021

Oct 06, 2021

BUY
$221.6 - $272.71 $221 - $272
1 Added 0.02%
4,600 $1.06 Million
Q2 2021

Jul 06, 2021

BUY
$180.55 - $233.54 $54,345 - $70,295
301 Added 7.0%
4,599 $1.06 Million
Q1 2021

May 26, 2021

BUY
$164.32 - $212.72 $706,247 - $914,270
4,298 New
4,298 $803,000
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $147,900 - $174,586
-1,993 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$81.94 - $87.89 $40,888 - $43,857
-499 Reduced 20.02%
1,993 $168,000
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $154 - $171
2 Added 0.08%
2,492 $213,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,490
2,490 $205,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Dallas Securities Inc. Portfolio

Follow First Dallas Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Dallas Securities Inc. with notifications on news.